Read the full article here.
This content was originally published by New York Times Dealbook. Original publishers retain all rights. It appears here for a limited time before automated archiving. By New York Times Dealbook
Well-timed stock bets have generated big profits for senior executives and board members at companies developing vaccines and treatments.